baber/WOPTO huggingface dataset:
Patent PT-80668-A (PT)
Title: Electromagnetic levitation casting apparatus having improved levitation coil assembly
IPC: B22D11/12
Filed: 1985-06-19
Abstract: An electromagnetic levitation casting apparatus having an improved levitation coil assembly employing flux concentration devices, is provided. The improved levitation coil assembly comprises a plurality of slotted annular slugs surrounding a tubular casting vessel within which a liquid metal column is to be levitated and solidified by cooling pursuant to the General Electric Levitation Casting (GELEC (TM)) process. Each of the slotted annular slugs is inductively coupled to a respective electromagnetic field producing coil having a large number of turns surrounding the slug. Each slotted annular slug serves to concentrate the magnetic field produced by its associated primary multi-turn coil to substantially the interior cross sectional area of the tubular casting vessel it surrounds and functions as a current step-up transformer. A separate slotted annular slug and associated surrounding electromagnetic multi-turn field producing coil is provided for each phase winding of the multiphase excitation employed in the improved levitation coil assembly.
Patent PT-81384-A (PT)
Title: Immunogenic complex a method for producing the same and the use thereof as an immune stimulant vaccines and reagensor
IPC: A61K39/44
Filed: 1985-10-28
Abstract: The invention relates to a process for preparing an immunogenic complex comprising a carrier molecule prepared by mixing viruses, mycoplasmas, bacterias, animal cells or proteins or peptides having hydrophobic regions with one or more solubilizing agents, whereby a complex having been formed between proteins or peptides and solubilizing agents, whereafter the proteins or the peptides have been separated from the solubilizing agent in the presence of a glycoside solution which contains one or more glycosides having hydrophobic and hydrophilic regions in a concentration of at least the critical micellular concentration, or alternatively have been separated from the solubilizing agent and transferred directly to the aforementioned glycoside solution, and the carrier molecule being bound to one or more molecules selected from peptides, proteins, carbohydrates, lipoproteins, glycolipides or small molecules, such as biotine, by coupling with known methods between functional coupling groups in the bound molecules and functional groups in the peptides or the proteins in the carrier molecule. 
<??>The invention also relates to a method for preparing such immunogenic complexes, compositions, vaccines containing such complexes and to reagents.
Patent PT-87949-A (PT)
Inventor: QUENTIN JEAN-PIERRE
IPC: C08G63/60
Filed: 1988-07-08
Abstract: Thermotropic aromatic copolyesters and copolyester amides capable of being shaped, of high molecular mass. 
<??>These polymers have a structure comprising repeat units of formulae (I), (II), (III), and (IV),
 (I) denoting: 
<IMAGE>
 - with A denoting an oxygen atom or the NH group, and they have a flow temperature ranging from 200 to 350 DEG C. 
<??>These polymers make it possible to obtain moulded objects, filaments and films endowed with good mechanical properties.
Patent PT-88256-A (PT)
Inventor: CUSSANS NIGEL JOHN
IPC: C07D217/06
Filed: 1988-08-12
Abstract: Isoquinoline antiarrhythmic agents of the formula:- <CHEM> and their pharmaceutically acceptable salts, wherein one of R<1> and R<2> is methoxy and the other is a group of the formula -OH, -O.CO(C1-C4 alkyl), -O.COPh or -O.COCH2Ph where Ph is a phenyl group optionally substituted by one or two substituents each independently selected from F, Cl, Br, I, CF3, C1-C4 alkyl and C1-C4 alkoxy.
Patent PT-89387-A (PT)
Inventor: CATON ANDRE
IPC: B65D71/00
Filed: 1989-01-03
Abstract: The present invention relates to means for making an assembly of empty or full bottles. This assembly comprises empty or full bottles (2) arranged vertically and superposed on one another, in different layers (3), each layer (3) being associated at the level of the bottoms and of the necks of the bottles with an insert (4, 5, 5a, 11) separating it from the adjacent layer (3) or from the outside of the assembly (1). Each insert (4, 5, 5a, 11) consists of an element having, on the one hand, a plurality of embossings (8, 8a) capable of interacting with the bottom of the bottles (2) forming a layer (3) so as to immobilise them with respect to one another, and, on the other hand, a plurality of centring orifices (9), each of which is capable of receiving the neck of a bottle (2) of the adjacent layer (3). <IMAGE>
Patent PT-89663-A (PT)
Inventor: CABRI WALTER
IPC: C07C50/38
Filed: 1989-02-09
Abstract: 4-Demethoxy-daunomycinone I: <CHEM> the known aglycone of 4-demethoxy-daunorubicin, is prepared by protecting the 13-keto group of 4-demethyl-daunomycinone, sulfonylating the 4-hydroxy group, reacting the sulfonylated compound with an amine, removing the amino protecting group from the resultant 4-demethyl-4-(protected amino)-13-dioxolanyl-daunomycinone, diazotising the thus-freed 4-amino group and reducing under mild conditions the resulting diazonium compound.
Patent PT-89963-A (PT)
Inventor: KURRLE ROLAND
IPC: G01N33/532
Filed: 1989-03-09
Abstract: The invention relates to magnetic protein conjugates of the general formula I <IMAGE> in which M is a dispersible, magnetically reacting material or particle which carries amino groups, P is a protein which carries one or more mercapto groups, and X is an organic chemical structure which links the two ligands by chemical means, to a process for the preparation of protein conjugates of the formula I and to the use of conjugates of this type for removing cells or soluble bioorganic molecules or components from aqueous salt solutions or body fluids, and to the use thereof in a diagnostic method or as diagnostic aid.
Patent PT-91890-A (PT)
IPC: A61M37/00
Filed: 1989-10-03
Abstract: Membrane for controlling agent delivery from an iontophoretic agent delivery device adapted to deliver the agent through an intact body surface is claimed,the device having a reservoir contg. the agent to be delivered and being connectable to a source of electrical power for driving the agent from the reservoir and through the body surface, in which the membrane is interposed between the agent reservoir and the body surface, the membrane permitting electrically-assisted flux (JEK) of the agent and preventing passive flux (Jp) of the agent, the membrane exhibiting a (JEK + Jp)/Jp ratio of at least 4, a voltage drop across the membrane of less than 1 volt and a Jp of less than 100 microgram/hr-cm2. The membrane may be formed by dissolving in a solvent, eg CH2Cl2 and CH3OH, 60-95 pts. wt. of cellulose acetate and 5-40 pts. wt. of a water soluble material, eg. polythylene glycol, having a mol. wt. at least great as the agent mol. wt., casting the membrane, evapg. the solvent and leaching out all of the water soluble material. Alternatively the membrane may comprise a mixt. of a hydrophilic resin, eg. PVP or an ion exchange resin having a functional gp. selected from sulphonic acid, carboxylic acid, imidodiatcetic acid and quaternary amines and hydrophobic polymer, eg. an ethylene vinyl acetate polymer having a vinyl acetate content of 1-40 wt. Also claimed is a method for testing performance characteristics of an iontophoretic agent delivery device adapted for delivering an agent through an intact body surface, using the membrane.
Patent PT-92454-A (PT)
Inventor: TWARDZIK DANIEL R
IPC: C12N15/12
Filed: 1989-11-29
Abstract: Recombinant transforming growth factor- beta 1 (TGF- beta 1) is expressed to high levels in Chinese hamster ovary (CHO) cells using dihydrofolate reductase (dhfr) gene amplification. The expression plasmid was derived from the pSV2 vectors and contained, in tandem, the simian TGF- beta 1 and mouse dhfr cDNAs. Transcription of both cDNAs was controlled by the SV40 early promoter. Stepwise selection of transfected CHO cells in increasing concentrations of methotrexate yielded cell lines expressing amplified TGF- beta 1 nucleic acid sequences. The expression plasmid DNA was amplified greater than 35-fold in one of the methotrexate selected transfectants. The major proteins secreted by these cells consisted of latent TGF- beta 1 and TGF- beta 1 precursor polypeptides as judged by immunoblots using site-specific anti-peptide antibodies derived from various regions of the TGF- beta 1 precursor. Levels of recombinant TGF- beta 1 protein secreted by these cells approached 30 ug/24 hour/10<7> cells. Expression vectors encoding TGF- beta 1 precursor variants which direct the synthesis and secretion of TGF- beta 1 in transfected mammalian cells are also described.
Patent PT-94051-A (PT)
Inventor: HENDERSON DAVID
IPC: A61K31/57
Filed: 1990-05-16
Abstract: Steroids having a 15,16-double bond, especially gestodene (17 alpha -ethynyl-17 beta -hydroxy-18-methyl-4,15-estradien-3-one), can be used for the treatment of carcinomas that can be inhibited in their growth by the protein TGF beta  (Tumor Growth Factor  beta ), especially breast carcinoma. At least one antiestrogen can be coadministered.
Patent SI-9110352-A (SI)
Title: Process for the production of pure salts of phosphoric (v) acid
Inventor: KRASOVEC LADISLAV
IPC: C01B25/46
Filed: 1991-02-28
Abstract: The invention refers to the production of pure salts of phosphoric (V) acid which is carried out in such a way that the hydroxide of a particular cation is added to the organic phase produced after the cleansing of the phosphoric acid obtained by means of the wet procedure with the solvent extraction with isopropanol in such a quantity that is determined on the basis of a multi-phase balance diagram, where constant mixing is necessary, the gained biphased mixture is separated and the phosphate is isolated from the solution of phosphate as the water phase.
Patent SI-9620040-A (SI)
Title: Process and crystal forms of 2-methyl-thieno-benzodiazepine
Inventor: BUNNELL CHARLES ARTHUR
IPC: C07B63/00
Filed: 1996-03-22
Abstract: The invention provides Form II, a pharmaceutically elegant, stable polymorph of olanzapine.
Patent SI-20636-A (SI)
Title: Method of formulating alkali metal salts
Inventor: PHINNEY ROBIN
IPC: C01D7/02
Filed: 1999-09-30
Abstract: Methodology for formulating sodium bicarbonate and potassium sulfate. In one embodiment, sodium sulfate and ammonium bicarbonate are reacted to form sodium bicarbonate with the remaining liquor or brine treated with sulfuric acid to remove carbonates with subsequent precipitation of potassium sulfate. A further embodiment employs ammonium bicarbonate, ammonia gas or carbon dioxide to precipitate sodium bicarbonate. The result of the methods is the production of high quality fertilizer and food grade sodium bicarbonate.
Patent UA-9501-A (UA)
Title: Sheet spring
Filed: 1989-07-26
Abstract: The invention relates to machine-building, sheet springs of transportation means. Sheet spring has sheets with constant thickness at length of sheets rigidly fixed in central part and pads installed between those at their ends.
Patent UA-12987-A (UA)
Title: Photoelectric method for determination of concentration of substances in liquid and gaseous media
Inventor: MYKHALEVYCH VOLODYMYR SERHIIOVYCH
Filed: 1991-04-04
Abstract: Photoelectric method for determination of concentration of substances in liquid and gaseous media at realization of which one forms monochromatic radiation with sounding component cuvette with it. Working chamber is filled with medium under investigation and comparison chamber – with comparison substance, one transforms with receiver of radiation monochromatic radiation passed into electric signal, for the last one logarithm is found, with measurement of value of electric voltage with following determination of concentration of medium under investigation by analytic relation.
Patent UA-11169-A (UA)
Title: Slider of lower part of sliding bearing
Filed: 1986-06-16
Abstract: Slider contains horizontal flat surface of slip and lubrication grooves executed in its upper part.
Patent RS-104504-A (RS)
Title: Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
Inventor: LIGHT DAVID
IPC: A61L33/00
Filed: 2003-04-30
Abstract: This invention relates to novel fusion proteins which are comprised of a targeting protein that binds tissue factor (TF), which is operably linked to the thrombomodulin (TM ) EGF456 domain alone or in combination with at least one other TM domain selected from the group consisting of the N-terminal hydrophobic region domain, the EGF123 domain, the interdomain loop between EGF3 and EGF4, and the O-glycosylated Ser/Thr-rich domain, or analogs, fragments, derivatives or variants thereof. The fusion protein binds at the site of injury and prevents the initiation of thrombosis. The fusion protein can be used to treat a variety of thrombotic conditions including but not limited to deep vein thrombosis, disseminated intravascular coagulation, and acute coronary syndrome.
Patent BG-106154-A (BG)
Title: Carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, methods for their production and their use as endothelin receptor antagonists
Inventor: AMBERG WILHELM
IPC: A61P9/10
Filed: 2001-11-27
Abstract: The invention relates to carboxylic acid derivatives of formula whereby the substituents have the meanings as explained in the description. The invention also relates to production and use of said novel carboxylic acid derivatives as endothelin receptor antagonists. 8 claims
Patent BG-106539-A (BG)
Title: Bicyclic androgen and progesterone receptor modulator compounds and methods
Inventor: ZHI LIN
IPC: A61K31/416
Filed: 2002-03-21
Abstract: The present invention is directed to compounds, pharmaceutical compositions, and methods for modulating processes mediated by AR and PR. More particularly, the invention relates to nonsteroidal compounds and compositions that are high affinity, high specificity agonists, partial agonists (i.e., partial activators and/or tissue specific activators and antagonists for AR and PR. Also provided are methods of making such compounds and pharmaceutical compositions, as well as critical intermediates used in their synthesis. 41 claims
Patent BG-110192-A (BG)
Title: A compound for tile production
Filed: 2008-07-29
Abstract: A compound based on magnesite cement, inorganic and organic fillers, surfactant additives provides the possibility to produce tiles free of internal stress and no cracks, leafing and other defects are detected. Tiles have high mechanical strength and durability. Their surface does not attract static electricity and it has photocatalytic activity giving under ultraviolet irradiation an air cleaning and antimicrobial effect. The compound improves reology and plastic properties of the initial mass to be processed in various manners - casting, compression, extrusion and self-levelling.
Patent BG-110734-A (BG)
Title: Метод за комуникация на мобилни абонати през виртуална учрежденска централа и система за осъществяването му
Inventor: IVANOV VENTSISLAV
IPC: H04L12/66
Filed: 2010-08-19
Abstract: Изобретението се отнася до метод за комуникация на мобилни абонати през виртуална учрежденска централа и система за осъществяването му, които могат да намерят приложение при изграждане на телекомуникационни системи за ефективно управление на комуникация между мобилни абонати. Методът и системата дават възможност на мобилните абонати да организират своите мобилни телефони в една логическа група, като същевременно ползват всички положителни характеристика на съвременна учрежденска централа с многобройни допълнителни услуги и методи за изграждане на интерактивност. Виртуалната учрежденска автоматична телефонна централа е свързана с комуникационната мрежа на поне един телекомуникационен оператор, при което към всеки телефонен номер на потребител се конфигурира най-малко един вътрешен за централата номер, от който могат да се инициират и приемат повиквания, както във виртуалната вътрешна телефонна мрежа на потребителя, така също и към публичната телефонна мрежа.
Patent CN-1281850-A (CN)
Title: 4－氯－2,2,6,6－四甲基哌啶的制备方法
Inventor: TIAN HE
IPC: C07D211/38
Filed: 2000-06-30
Abstract: 本发明属于精细化工领域,公开了一种4－氯－2,2,6,6－四甲基哌啶的制备方法。本发明以4－羟基－2,2,6,6－四甲基哌啶为原料,以氯化亚砜为氯化试剂,以季铵盐氯化物为催化剂,合成了4－氯－2,2,6,6－四甲基哌啶。所说的方法反应条件温和,反应产率高,污染小,是一种便于工业化生产4－氯－2,2,6,6－四甲基哌啶的方法。
Patent CN-1306254-A (CN)
Title: 用于散布一个真实或虚拟网址的占用率的装置
Inventor: AHEBI A
IPC: G06Q10/00
Filed: 2000-12-21
Abstract: 本发明所涉及的用于散布至少一个信息项的装置的特征在于,它包括用于同时向广泛的公众散布一个可察觉的并且代表所述信息的信号的装置,其特征还在于,所述信息是一个真实或虚拟网址的占用率,具体地是一个计算机网络地址,特别是互联网类型的。
Patent CN-1367812-A (CN)
Title: 可燃性废弃物的处理方法
Inventor: ICHIRO UENO
IPC: C10L5/46
Filed: 2000-08-03
Abstract: 可燃性废弃物的处理方法是由用于得到干馏碳化物和可燃性气体,对可燃性废弃物进行干馏的工序、为了净化过程中排放气体,把干馏碳化物吹入到过程中的排放气体中的工序、用集尘装置回收过程中排放气体中的干馏碳化物的工序组成。干馏至少要在400℃以上的温度下进行。
Patent CN-1380310-A (CN)
Title: 一种多肽——环指蛋白－24.20和编码这种多肽的多核苷酸
Inventor: MAO YUMIN
IPC: C12N15/113
Filed: 2001-04-10
Abstract: 本发明公开了一种多肽——环指蛋白-24.20,编码此多肽的多核苷酸和经DNA重组技术产生这种多肽的方法。本发明还公开了此多肽用于治疗多种疾病的方法,如恶性肿瘤,血液病,HIV感染和免疫性疾病和各类炎症等。本发明还公开了抗此多肽的拮抗剂及其治疗作用。本发明还公开了编码这种新的环指蛋白-24.20的多核苷酸的用途。
Patent CN-1306188-A (CN)
Title: 具有断电记忆的冷柜
Inventor: MA JIAN
IPC: F25D29/00
Filed: 2001-01-22
Abstract: 本发明提供一种具有断电记忆的冷柜,包括控温系统,其特征在于所述的控温系统中含有断电记忆温度判定程序,断电后重新来电时,控温系统通过感温元件采集此刻冷柜箱内的温度T,并依据此温度T,通过预设的判定条件,程序自动感应、判断并进入断电前(或最接近断电前)的温度控制状态运行。其断电记忆时间较长,无需增设电容(或电池)、记忆芯片等电子元件,成本低,控制准确可靠。
Patent CN-1403946-A (CN)
Title: 在决策信息系统上自动以电子邮件发送讯息的方法
Inventor: QIU HONGLIANG
IPC: G06F17/00
Filed: 2001-09-06
Abstract: 一种在决策信息系统上自动以电子邮件发送讯息的方法，为解决信息传送过程中无法进行自动化处理，而借助决策信息系统控管所有异常的讯息，并通过电子邮件通知至少一个使用者端，将重要信息主动传达，实现决策单位主动掌握有效的信息。
Patent CN-1341949-A (CN)
Title: 指引管
Inventor: BETSYTA H-H
IPC: H01J31/20
Filed: 2001-08-28
Abstract: 本发明涉及一种阴极射线管,其中通过把导体轨道(12、13)安排在每个荧光条纹的下面来确定电子射线(7,8,9)的位置。导体轨道(12、13)部分地用一种绝缘层(14)覆盖,以致于可以使用具有大直径的一个电子射线(7,8,9)。
Patent CN-1449407-A (CN)
Title: 生理学上可接受的强酸加成盐形式的在其n－末端含有一个谷氨酸或一个谷氨酰胺的药用分子
Inventor: CHRISTINE KLINGUER-HAMOUR
IPC: C07K1/06
Filed: 2001-03-22
Abstract: 本发明涉及以生理上可接受的强酸加成盐形式存在的在其N－末端含有一个谷氨酸或一个谷氨酰胺的药用分子，优选地是主要组织相容性复合体(MHC)配体，以及含有这样一种配体的疫苗。
Patent CN-1502207-A (CN)
Inventor: TINKU ACHARYA
IPC: H04N19/137
Filed: 2001-12-27
Abstract: 揭示了用于使用比特预算进行视频编码速率控制的方法的实施例。
Patent CN-1558984-A (CN)
Title: 涡轮叶片
Inventor: SHIGEKI SENOO
IPC: F01D5/14
Filed: 2001-10-10
Abstract: 本发明的目的是提供一种能够降低翼型损失的涡轮叶片。为实现上述目的，本发明的涡轮叶片为，在由工作流体驱动的涡轮的周方向上设置多个的涡轮叶片，其特征在于，以由叶片负压面侧的翼面曲率半径的倒数定义的叶片负压面曲率从由叶片的轴方面最上游点定义的叶片前缘开始直到叶片的轴方向最下游点定义的叶片后缘为止单调减少的状态形成。
Patent CN-1489958-A (CN)
Inventor: YANG ZONGLONG
IPC: A45F5/10
Filed: 2002-10-17
Abstract: 一种可携式装置的颈部吊带，特别是有关于一种具有快速脱离单元(Quick Release Unit)的颈部吊带，此快速脱离单元位于颈部与此可携式装置的连接部分之间，当外力拉扯此颈部吊带的拉扯力量超过一安全范围后，此快速脱离单元能快速脱落，以维护使用者的生命安全。而此增加的快速脱落单元，不会碰触到使用者的颈部，因此不会让使用者有不舒服的感觉。而且设计上不需考虑人体工学，因此并不限于任何的形状，大幅提高设计的弹性。
Patent CN-1415779-A (CN)
Title: 溅射法生产高稳定性金属膜电阻器用的高阻靶材制造方法
Inventor: ZHANG ZHISHENG
IPC: C22C1/02
Filed: 2002-10-28
Abstract: 本发明公开了一种溅射法生产高稳定性金属膜电阻器用高阻靶材制造方法。该方法主要包括原料的配比、熔炼、浇铸和线切割过程。其特征在于：原料的组分及其重量含量为，Si：45～55％，Cr：40～50％，Ni：3～6％，Ti：0.1～0.3％。熔炼采用刚玉－石墨－镁砂复合型真空感应炉，熔炼温度为1500℃～1550℃，时间为1h，模壳内设置管口伸至模壳底面的浇铸管，烘烤模壳，使其温度达650℃～700℃时，料液通过浇铸管底面浇铸。浇铸后膜壳缓慢冷却至850℃～800℃，保温一小时，然后再以10℃～15℃/h的速度进行冷却至室温。本发明的优点在于，制备的靶材表面光滑、平整、外部无裂纹，内部无气孔。生产的金属膜电阻器具有高稳定性能，阻值达100Ω～20kΩ(未刻槽)。
Patent CN-1428336-A (CN)
Title: 一氧化氮合酶抑制剂及其制备方法和用途
Inventor: XU YUNGEN
IPC: A61P3/10
Filed: 2002-12-27
Abstract: 本发明涉及新的通式为(I)的化合物，其中R 1 表示氢、氯、溴、甲基或甲氧基；R 2 表示氢、C 1－4 的烷基或苯基；R 3 表示C 1－4 的烷基、烯丙基、苄基或取代苄基；X表示氮或硫。本发明还公开了通式(I)化合物的制备方法，含I的药物组合物，及其用于治疗败血性休克、肠炎、风湿性关节炎、糖尿病、大脑缺血性损伤和早老性痴呆等的用途。
Patent CN-1611040-A (CN)
Inventor: TAMAS MAJOR
IPC: H04L12/947
Filed: 2002-12-23
Abstract: 本发明涉及一种网络元件和相关方法，它们通过使用基于LAN的链路系统促进了数据帧在网络元件的基本设备(U1－Um)之间的通信。加到多端口接口转换器的端口的数据被格式化为数据帧，该数据帧可能选择性地包括由IEEE 802.1Q标准中定义的VID(虚拟LAN标识符)填充的Q标记前缀。如果要由多端口接口转换器传输的数据是源于该转换器，该数据就被格式化为数据帧，但是不包括该前缀结构，因此，该帧不用VID填充。当数据帧是在路由器设备接收到时，对数据帧是否包括前缀结构进行检测。响应于该前缀结构是否由数据帧中包含的VID构成，而进行该数据帧的数据的路由选择。此外，活动和非活动单元的活动状态能够使用建议的基于LAN的链路系统被用信号通知出去。因此，网络元件的基本设备之间的通信可被促进而复杂度可被降低。
Patent CN-1610874-A (CN)
Inventor: TAKESHI SENPUKU
IPC: H04M1/00
Filed: 2002-03-08
Abstract: 本发明的移动通信装置，具有第1显示装置(3a)和第2显示装置(3b)。其中第2显示装置(3b)设置为可相对于壳体移动，第2显示装置(3b)的移动通过传感器(7)检测。又，移动体通信装置具备执行应用程序的控制装置(1)，在第2显示装置移动时，与该移动联动，自动更新第1显示装置(3a)或第2显示装置(3b)的显示内容。在第2显示装置从闭状态变化为开状态的情况下，控制装置(1)自动选择与第1显示装置(3a)的显示内容相关的显示，显示于第2显示装置上。借助于此，用户只使第2显示装置移动，就能够自动获得与这时的使用状况相对应的显示内容，能够提供优异的用户接口。
Patent CN-1694799-A (CN)
Inventor: CLAUDIO LACAGNINA
IPC: B29D30/20
Filed: 2002-11-05
Abstract: 轮胎(2)的胎体结构(3)在初级鼓(13)上形成，而带结构(4)以及其后胎面带(5)在辅助鼓(15)上制成，以便随后与胎体结构(3)相连接。辅助鼓(15)由一机械臂(19a)支承，该机械臂引起所述辅助鼓在两个位置之间的平移，其中一个位置与初级鼓(13)共轴对准，在该位置上辅助鼓(15)与带层供料线(16)相互作用，而另一个位置上则与供应连续条带状构件的至少一个挤压机(18，18a)相互作用。机械臂(19a)使辅助鼓(15)在挤压机(18，18a)前面移动，以便以连续圆周匝形式分布条带状构件，从而形成胎面带(5)。
Patent CN-1553217-A (CN)
Inventor: WAN WENMAN
IPC: G01V1/143
Filed: 2003-05-29
Abstract: 本发明涉及石油和地质勘探技术领域，具体涉及一种用于套管深井的震源设备。本发明要克服现有技术存在的设备庞大，技术复杂，维修难度大，成本高的缺陷。为克服现有技术的缺陷，本发明的技术解决方案是，一种用于套管深井的震源设备，包括外壳2和其内的震源动力电机，其特殊之处在于：还包括外壳2内的激震器，所述激震器包括锤砧座5和与锤砧座5配合的推靠块6，所述锤砧座5与直线电机的次极锤杆4同轴。
Patent CN-1643142-A (CN)
Title: 鉴定控制分化的基因的方法
Inventor: THOMSON JAMES A
IPC: C12Q1/68
Filed: 2003-03-14
Abstract: 描述了负责基于表达克隆的细胞分化的遗传因子的鉴定方法。为确定那一种遗传因子导致细胞从起始细胞类型分化成靶细胞类型，获得了一种cDNA文库，将其包装在表达载体中并转化入起始细胞类型的细胞。表达载体还优选包括一种标记基因系统，所述系统在靶细胞类型的组织类型中可操作的组织特异性启动子的控制下。然后培养转化的细胞直到细胞分化开始，然后筛选或选择培养物以鉴定分化成靶细胞类型的细胞。通过检测分化细胞中的cDNA插入物可鉴定负责分化过程的遗传因子。
Patent CN-1656809-A (CN)
Inventor: LAURENT FAY
IPC: H04N7/24
Filed: 2003-05-05
Abstract: 本发明涉及具有自适应比特率(称之为数据比特率)的数据流经由具有可变信道传输速率的传输信道的传输。接收器包括接收缓冲器和解码器。按照本发明：a)估算在所说接收缓冲器中数据缺乏和数据溢出的危险；b)计算当前的信道传输速率的估算值；c)如果存在数据缺乏的危险或数据溢出的危险，则根据所说的当前信道传输速率的估算值触发所说数据比特率的自适应调节。
Patent CN-1662223-A (CN)
Inventor: BRIAN STRONG
IPC: A61K31/135
Filed: 2003-06-25
Abstract: 制备球形微丸的方法，该球形微丸含有(a)在水中能够溶解、易于溶解或十分易溶的水溶性活性成分，特别是具有≥0.5g/ml的水溶性；(b)滚圆剂；(c)干燥润滑剂，所述方法包括制备活性成分、滚圆剂、干燥润滑剂的混合物；和相对于混合物的总重量低于5％w/w的量的水；挤出该混合物以获得挤出物；并滚圆挤出物以形成球形微丸。本发明进一步涉及通过该方法获得的微丸利以及含有该微丸的缓释口服剂型。
Patent CN-1662707-A (CN)
Inventor: RICHARD AUST
IPC: B05C5/00
Filed: 2003-06-02
Abstract: 本发明涉及一种用于制造和处理或用于处理料幅优选纸幅或纸板幅的机器，按本发明建议，设至少一个包括至少一个不接触式涂敷机构的涂敷装置(20a－1)，并与至少一个料幅平整机构(40a－1)相结合。本发明的机器一方面可以按不接触的方式将液态或糊状的涂敷介质涂敷到连续料幅(M)的至少一面上，且另一方面可以在在线过程或脱线过程中，在介质涂敷前或/和后平整连续的料幅(M)。
Patent CN-1666501-A (CN)
Inventor: CRISTIANO CASTELLO
IPC: H04N5/335
Filed: 2003-06-23
Abstract: 建议了一种用于对来自一个像素矩阵的废弃或者干扰像素的像素信息进行动态修复的实时像素校正算法。该算法适用于CCD和CMOS成像器。
Patent CN-1665912-A (CN)
Inventor: EVERA HUBBERS THEODORUS PETRUS
IPC: C07C7/12
Filed: 2003-06-27
Abstract: 本发明公开了从由裂化烃流而得到的裂化气体中回收含乙烯和丙烯流的方法，其中在－10℃和－40℃之间的温度下，在吸收性脱甲烷塔中用C 4 /C 5 溶剂处理裂化气，从而从裂化气中脱除甲烷和氢气，随后在蒸馏单元中蒸馏处理余下的流，以得到含C 4 /C 5 的流以及含乙烯和丙烯的流；随后在氢化单元中用含氢的流处理C 4 /C 5 流，随后一部分经氢化的C 4 /C 5 流被冷却至在－10℃和－40℃之间的温度，并被再循环到吸收性脱甲烷塔中，而一部分经氢化的C 4 /C 5 流被分离出。
Patent CN-1672378-A (CN)
Inventor: WILLMUT ZSCHUNKE
IPC: H04L25/03
Filed: 2003-07-29
Abstract: 本发明涉及一种通过分隔QPSK信号的频谱将QPSK信号的比特率分配到至少两个在调制器和解调器中具有限带滤波器的信道上的方法。经过预先滤波的QPSK信号在发送端被分成至少一个实频谱和至少一个虚频谱，并以频分复用进行传输，并且在发送器的调制器和接收器的解调器中的滤波器根据传递函数来确定。
Patent CN-1684899-A (CN)
Inventor: PETER MAURER
IPC: B66C13/06
Filed: 2003-09-24
Abstract: 本发明涉及一种起重机载荷(24)位置准确地定位的方法和相应的设备。起重机有吊运小车(3)和升降装置，后者包括至少四个提升机构(4－7)，它们各有一个卷绳筒(9－11)和自己的驱动器(16－19)，其中，每个卷绳筒(9－11)通过钢绳(12－15)与载荷承接装置(23)和/或载荷(24)连接。可以检测载荷(24)的位置。当载荷(24)旋转摆动时，可通过四个驱动器更好地制止旋转摆动。
Patent CN-1842512-A (CN)
Inventor: GAINER JOHN L GRABIAK RAYMOND
IPC: A01N37/00
Filed: 2003-08-25
Abstract: 本发明涉及反式类胡萝卜素盐化合物、其制备方法、其溶解方法及其使用方法。这些化合物有益于提高包括人在内的哺乳动物中红细胞与机体组织间氧的扩散性。
Patent CN-85104217-A (CN)
IPC: B29C43/44
Filed: 1985-06-01
Abstract: 本发明介绍一种用于热塑性塑料薄膜或其它需要压花材料的压花压光机，这种压花压光机不仅能使压花辊而且也能使副压辊进行相当快速更换，这种快速更换过程是通过把压花压光机分成二个机械部件，即分成一个使压花辊进行轴向导向的夹持框架；另一个使副压辊能径向移动的转动框架支架来实现的。
Patent CN-1061284-A (CN)
Inventor: YUANQING ZHU
IPC: G01N9/12
Filed: 1991-12-06
Abstract: 本发明是一种专用于测量植物油的密度计，它由
压载室、躯体和干管组成，压载室中有密封的铅丸，紧
贴于干管内壁有一刻度均匀的密度示值表。该密度
计不确定度为万分之三，每测量一次样品密度只需
10分钟，解决了国内外目前测量植物油密度的难
题。节约了检测费用和测量时间。
Patent CN-1060988-A (CN)
Title: 一种环形金属零件的加工方法
Inventor: GONGSHENG WU
IPC: B23P13/00
Filed: 1991-09-25
Abstract: 本发明涉及一种用于环形金属机械零件的加工

方法。其特征是采用金属线材将其卷弯成圆环，并对

其接口进行焊接，再经过挤压成型。本发明的方法提

高了材料的利用率。简化了加工工序，提高了工效，

降低了成本，实用性强，易于推广。
Patent CN-1113832-A (CN)
Title: 氨合成催化剂及制备方法
Inventor: RUYU XU
IPC: B01J23/76
Filed: 1994-06-21
Abstract: 一种氨合成催化剂及制备方法，该催化剂是以铁
的氧化物为主要成分，以氧化铝、氧化钾、氧化钙、混
合稀土氧化物及其它金属氧化物为助剂，催化剂的铁
比值为0.4～16，催化剂由熔融法制备。该催化剂具
有低温高催化活性，优良的耐热抗毒性能，使用寿命
长，制造成本较低。该催化剂适用于各类氨厂，增产、
节能。降耗效果显著，具有较大的经济效益和社会效
益。